logo
Share SHARE
FONT-SIZE Plus   Neg

Oramed'PlatformTech In Oral Delivery Of Proteins Gets Patent In Israel,Australia

Oramed Pharmaceuticals Inc. (ORMP: Quote), a developer of oral drug delivery systems, announced Thursday that it has received Notices of Allowance from the Israel and Australian Patent Offices.

The patent entitled, "Methods and Compositions for Oral Administrations of Proteins" covers a core concept of the company's technology for the oral delivery of drugs and vaccines currently delivered via injection.

The company stated that the allowance in Israel marks the second from the Israel Patent Office in the past 30 days. Additionally, this is Oramed's second Australian patent allowance, following the grant of a different patent in May 2012.

The company noted that the patent has also been approved in Japan, China, Russia, and New Zealand.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Apple Watch is expected to post robust sales in the first weekend after its launch on April 24. A craze for Apple Watch may catapult the smartwatch industry into a lucrative market, while a not-so-impressive response for the Apple device may weigh on the industry. Fast food giant McDonald's Corp. (MCD), in a bid to boost slowing sales, is all set to make changes to its grilled chicken recipe by removing ingredients that may sound like chemicals to customers. The news was first reported by Associated Press, which said the new Artisan Grilled Chicken will no... GoDaddy Inc (GDDY) shares surged in its debut on the New York Stock Exchange following a successful initial public offering. GoDaddy, a technology provider dedicated to small businesses, priced its IPO of 23 million Class A shares at $20.00 each, above its estimated range of $17 to $19 per share. All...
comments powered by Disqus
Follow RTT